Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics. The company's Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, KaVo, Kerr, Metrex, Sybron Endo, Total Care, and Pentron brands to dental offices, clinics, and hospitals. The company was incorporated in 2018 and is headquartered in Brea, California.
IPO Year: 2019
Exchange: NYSE
Website: envistaco.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/31/2024 | $16.00 → $23.00 | Underperform → Market Perform | Leerink Partners |
| 10/8/2024 | $20.00 | Equal Weight | Wells Fargo |
| 8/8/2024 | $23.00 → $16.00 | Overweight → Neutral | JP Morgan |
| 4/26/2024 | $33.00 → $21.00 | Overweight → Equal-Weight | Morgan Stanley |
| 2/26/2024 | $19.00 | Underperform | Leerink Partners |
| 2/9/2024 | $30.00 → $23.00 | Buy → Hold | Jefferies |
| 2/8/2024 | Outperform → Mkt Perform | William Blair | |
| 1/5/2024 | $26.00 | Neutral | UBS |
| 12/11/2023 | $22.00 | Buy → Sell | Goldman |
| 11/16/2023 | Hold | Needham |
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
3 - Envista Holdings Corp (0001757073) (Issuer)
BREA, Calif., Oct. 30, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the third quarter of 2024. For the quarter ended September 27, 2024, reported sales were $601.0 million. Core sales in the quarter declined 5.3% over the corresponding quarter in 2023. Net income in the third quarter was $8.2 million or $0.05 per diluted share, compared to net income of $21.5 million or $0.12 per diluted share in Q3 2023. Adjusted net income for the third quarter of 2024 was $21.1 million or $0.12 per diluted share, compared to adjusted net income
BREA, Calif., Oct. 7, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its third quarter 2024 on Wednesday, October 30, 2024. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour. The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. Y
BREA, Calif., Aug. 7, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the second quarter of 2024. For the quarter ended June 28, 2024, reported sales were $633.1 million. Core sales in the quarter declined 3.2% over the corresponding quarter in 2023. Net loss in the second quarter was $1,151.6 million or $6.69 per share. The net loss included a $1,153.8 million non-cash charge related to the impairment of goodwill and intangible assets. During the same period, adjusted net income was $18.5 million or $0.11 per diluted share compared
BREA, Calif., July 12, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its second quarter 2024 on Wednesday, August 7, 2024. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour. The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. Y
BREA, Calif., May 1, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the first quarter of 2024. For the quarter ended March 29, 2024, reported sales were $623.6 million. Core sales in the quarter increased 0.4% over the corresponding quarter in 2023. For the first quarter of 2024, net income was $23.6 million or $0.14 per diluted share. During the same period, adjusted net income was $45.8 million or $0.26 per diluted share compared to adjusted net income of $67.8 million or $0.38 per diluted share in the same period of 2023. Adjusted
BREA, Calif., April 4, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its first quarter 2024 on Wednesday, May 1, 2024. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour. The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You c
BREA, Calif., Feb. 7, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the fourth quarter and full year 2023. For the quarter ended December 31, 2023, reported sales were $645.6 million. Core sales in the quarter declined 2.0% over the corresponding quarter in 2022. Net loss in the fourth quarter was $217.4 million or $1.27 per diluted share. The net loss included a $258.3 million non-cash charge related to the impairment of goodwill and intangible assets. During the same period, adjusted net income was $49.7 million or $0.29 per di
BREA, Calif., Jan. 11, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its fourth quarter 2023 on Wednesday, February 7, 2024. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour. The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year.
BREA, Calif., Oct. 5, 2023 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its third quarter 2023 on Wednesday, November 1, 2023. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour. The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. Y
BREA, Calif., Aug. 7, 2023 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") today announced the pricing of its offering of $435,000,000 in aggregate principal amount of its 1.75% Convertible Senior Notes due 2028 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The issuance and sale of the notes are scheduled to settle on August 10, 2023, subject to customary closing conditions. Envista also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to
SC 13G - Envista Holdings Corp (0001757073) (Subject)
SC 13G/A - Envista Holdings Corp (0001757073) (Subject)
SC 13G - Envista Holdings Corp (0001757073) (Subject)
SC 13G/A - Envista Holdings Corp (0001757073) (Subject)
SC 13G/A - Envista Holdings Corp (0001757073) (Subject)
SC 13G/A - Envista Holdings Corp (0001757073) (Subject)
SC 13G/A - Envista Holdings Corp (0001757073) (Subject)
SC 13G/A - Envista Holdings Corp (0001757073) (Subject)
SC 13G - Envista Holdings Corp (0001757073) (Subject)
SC 13G - Envista Holdings Corp (0001757073) (Subject)
8-K - Envista Holdings Corp (0001757073) (Filer)
SCHEDULE 13G - Envista Holdings Corp (0001757073) (Subject)
10-Q - Envista Holdings Corp (0001757073) (Filer)
8-K - Envista Holdings Corp (0001757073) (Filer)
S-8 - Envista Holdings Corp (0001757073) (Filer)
10-Q - Envista Holdings Corp (0001757073) (Filer)
8-K - Envista Holdings Corp (0001757073) (Filer)
8-K - Envista Holdings Corp (0001757073) (Filer)
11-K - Envista Holdings Corp (0001757073) (Filer)
SD - Envista Holdings Corp (0001757073) (Filer)
BREA, Calif., Nov. 20, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced the release of its 2023 Sustainability Report, outlining its continued efforts to integrate environmental, social, and governance (ESG) considerations into its mission to digitize, personalize, and democratize dental care. The full report can be found HERE. "Our efforts to promote improved environment, social, and governance initiatives are central to how we support our stakeholders. Through the lens of our key areas of focus – Delivering Quality and Access; Supporting Our Peop
BREA, Calif., Nov. 19, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") today announced that the company will participate in a fireside chat at the Evercore HealthCONx Conference on Tuesday, December 3, 2024 from 12:30 – 1:15 pm ET at the Loews Coral Gables Hotel in Coral Gables, Florida. There will be an audio-only recording link that can be viewed on Envista's Investor Relations website for up to 365 days post event. ABOUT ENVISTA HOLDINGS CORPORATION Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DE
BREA, Calif., Oct. 30, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the third quarter of 2024. For the quarter ended September 27, 2024, reported sales were $601.0 million. Core sales in the quarter declined 5.3% over the corresponding quarter in 2023. Net income in the third quarter was $8.2 million or $0.05 per diluted share, compared to net income of $21.5 million or $0.12 per diluted share in Q3 2023. Adjusted net income for the third quarter of 2024 was $21.1 million or $0.12 per diluted share, compared to adjusted net income
BREA, Calif., Oct. 7, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its third quarter 2024 on Wednesday, October 30, 2024. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour. The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. Y
QUAKERTOWN, PA / ACCESSWIRE / September 24, 2024 / At the start of 2024, DEXIS introduced its digital ecosystem, a suite of tools and software designed to connect and streamline the implant workflow from diagnosis to delivery. Today, DEXIS announced upgrades across the ecosystem to aid clinicians in important workflow elements from visualizing progressive dental issues to designing chairside surgical guides."Our technology makes it easy to organize information and execute treatments, which is at the core of what clinicians expect from us," said DEXIS President, Robert Befidi. "We are connecting and standardizing the implant workflow while also constantly evaluating our efforts to ensure we
BREA, Calif., Aug. 27, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") today announced that the company will participate in the Baird 2024 Global Healthcare Conference on Wednesday, September 11, 2024 from 10:50 – 11:20 am ET at the InterContinental New York Barclay. There will be no recording link available for this event. ABOUT ENVISTA HOLDINGS CORPORATION Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envis
WESTPORT, Conn., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE:CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that Stephen Keller has been appointed as the Company's Chief Financial Officer (CFO), effective August 31, 2024. He will be replacing Ryan Faulkingham, who has served as the Company's CFO since July 2013 and is departing the Company effective August 30, 2024. Mr. Faulkingham will continue to serve in an advisory capacity in order to facilitate a seamless transition. In his new role, Mr. Keller will lead CODI's finance organization, including accounting, planning, treasury, tax, reporting, and investor relations. He b
BREA, Calif., Aug. 7, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the second quarter of 2024. For the quarter ended June 28, 2024, reported sales were $633.1 million. Core sales in the quarter declined 3.2% over the corresponding quarter in 2023. Net loss in the second quarter was $1,151.6 million or $6.69 per share. The net loss included a $1,153.8 million non-cash charge related to the impairment of goodwill and intangible assets. During the same period, adjusted net income was $18.5 million or $0.11 per diluted share compared
BREA, Calif., July 15, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced the following key leadership appointments: Eric Hammes joins Envista as Chief Financial OfficerStefan Nilsson joins Envista as President, Nobel BiocareVeronica Acurio joins Envista as President, Ormco"It is a pleasure to welcome this trio of successful leaders to Envista," said Paul Keel, Chief Executive Officer. "Each brings experience in dental along with a proven track record of continuous improvement, leading with purpose, and creating value for all stakeholders. Today's an
BREA, Calif., July 12, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its second quarter 2024 on Wednesday, August 7, 2024. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour. The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. Y
Leerink Partners upgraded Envista from Underperform to Market Perform and set a new price target of $23.00 from $16.00 previously
Wells Fargo initiated coverage of Envista with a rating of Equal Weight and set a new price target of $20.00
JP Morgan downgraded Envista from Overweight to Neutral and set a new price target of $16.00 from $23.00 previously
Morgan Stanley downgraded Envista from Overweight to Equal-Weight and set a new price target of $21.00 from $33.00 previously
Leerink Partners initiated coverage of Envista with a rating of Underperform and set a new price target of $19.00
Jefferies downgraded Envista from Buy to Hold and set a new price target of $23.00 from $30.00 previously
William Blair downgraded Envista from Outperform to Mkt Perform
UBS initiated coverage of Envista with a rating of Neutral and set a new price target of $26.00
Goldman downgraded Envista from Buy to Sell and set a new price target of $22.00
Needham initiated coverage of Envista with a rating of Hold
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
4 - Envista Holdings Corp (0001757073) (Issuer)
Baird analyst Jeff Johnson maintains Envista Holdings (NYSE:NVST) with a Neutral and lowers the price target from $19 to $17.
Envista Holdings (NYSE:NVST) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 2 0 1 Last 30D 0 0 0 0 0 1M Ago 0 1 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 1 2 0 1 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $19.9, along with a high estimate of $23.00 and a low estimate of $17.50. A decline of
Needham analyst David Saxon reiterates Envista Holdings (NYSE:NVST) with a Hold.
Stefan Nilsson joins Envista as President, Nobel Biocare Veronica Acurio joins Envista as President, Ormco Hammes succeeds Stephen Keller who has served as Interim Principal Financial Officer since September 2023. Keller will return to his previous role leading investor relations.
Envista Holdings (NYSE:NVST) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 2 2 0 1 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 2 0 1 3M Ago 0 0 0 0 0 Analysts have recently evaluated Envista Holdings and provided 12-month price targets. The average target is $19.9, accompanied by a high estimate of $23.00 and a low estimate of $17.50. Observing a downw
Evercore ISI Group analyst Elizabeth Anderson maintains Envista Holdings (NYSE:NVST) with a Outperform and lowers the price target from $24 to $19.
Across the recent three months, 4 analysts have shared their insights on Envista Holdings (NYSE:NVST), expressing a variety of opinions spanning from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 1 2 0 1 Last 30D 0 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 2 0 1 3M Ago 0 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $20.12, along with a high estimate of $23.00 and a low estimate of $17.
Needham analyst David Saxon reiterates Envista Holdings (NYSE:NVST) with a Hold.
Goldman Sachs analyst Nathan Rich maintains Envista Holdings (NYSE:NVST) with a Sell and lowers the price target from $20 to $17.5.
JP Morgan analyst Rachel Vatnsdal maintains Envista Holdings (NYSE:NVST) with a Overweight and lowers the price target from $29 to $23.
WESTPORT, Conn., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE:CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that Stephen Keller has been appointed as the Company's Chief Financial Officer (CFO), effective August 31, 2024. He will be replacing Ryan Faulkingham, who has served as the Company's CFO since July 2013 and is departing the Company effective August 30, 2024. Mr. Faulkingham will continue to serve in an advisory capacity in order to facilitate a seamless transition. In his new role, Mr. Keller will lead CODI's finance organization, including accounting, planning, treasury, tax, reporting, and investor relations. He b
BREA, Calif., July 15, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced the following key leadership appointments: Eric Hammes joins Envista as Chief Financial OfficerStefan Nilsson joins Envista as President, Nobel BiocareVeronica Acurio joins Envista as President, Ormco"It is a pleasure to welcome this trio of successful leaders to Envista," said Paul Keel, Chief Executive Officer. "Each brings experience in dental along with a proven track record of continuous improvement, leading with purpose, and creating value for all stakeholders. Today's an
BREA, Calif., April 15, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) announced today the appointment of Paul Keel as Chief Executive Officer and a member of the Board of Directors effective May 1, 2024. He succeeds Amir Aghdaei, who will continue to support the transition as a senior advisor. "Paul's strong track record as CEO of a public, diversified, global innovation company makes him the right leader for Envista at this stage in our growth journey," said Scott Huennekens, chairman of Envista. "His pertinent combination of accelerating growth and operationa
BREA, Calif., Feb. 26, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) announced today that the Board of Directors and CEO Amir Aghdaei are formally launching a process to determine a successor for CEO. The Board of Directors has formed a search committee and retained an executive search firm to find qualified external candidates to lead the next phase of Envista. This process is expected to be completed this year. Mr. Aghdaei will remain President and CEO until his successor is appointed. "After nearly 10 years leading Danaher's Dental Platform and the Envista t
BREA, Calif., Dec. 14, 2023 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced the expansion of its leadership team, with the recent appointments of Robert Befidi as President, Diagnostics; Suraj Satpathy as Chief Human Resources Officer; and Andrew Chen as Chief Information Officer. Robert Befidi joins Envista from 3M, where he most recently was President of the Separation and Purification Sciences Division, a global filtration technology leader. He has held several senior executive roles in the 3M Health Care Business Group, including leading Global M
SAN JOSE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today the appointment of Tamara Elias, M.D., Senior Vice President at Nuance, and Scott Huennekens, executive chairperson at Hyperfine, Wondr Medical, Acutus Medical and Envista Holdings Corporation, to the BrightInsight Advisory Council. Dr. Elias and Huennekens bring deep and complimentary experience to this group of industry experts, who work with BrightInsight leadership to advance the company's vision to transform patient outcomes globally through the power of digital technology. Dr. Elias and Huennek